Revelation Biosciences, Inc.
REVB
$3.08
$0.082.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.04M | -15.52M | -15.90M | -8.96M | -120.30K |
| Total Depreciation and Amortization | 27.90K | 27.00K | 26.10K | 25.20K | 25.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 112.50K | 6.40K | -80.20K | -496.70K | -8.17M |
| Change in Net Operating Assets | -3.42M | -1.09M | 6.92M | 883.40K | 982.10K |
| Cash from Operations | -18.32M | -16.58M | -9.04M | -8.55M | -7.29M |
| Capital Expenditure | -19.20K | -36.90K | -19.20K | -19.20K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19.20K | -36.90K | -19.20K | -19.20K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.85M | 9.16M | 5.42M | 5.42M | 14.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | -5.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.85M | 9.16M | 5.42M | 5.42M | 14.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.49M | -7.45M | -3.64M | -3.15M | 6.74M |